bioMérieux : La part du rêve …et de réalité
>Tests COVID-19: quel surcroît de CA ? - Les tests COVID pourraient représenter un volume d’activité proche de 240-250 M€e sur 2020, permettant à bioMérieux de dépasser les objectifs qu’il s’était fixés (croissance +5/+7% et ROC : 395-415 M€), fin février, avant que la crise de la COVID ne prenne l’ampleur que l’on connait.Au passage, on notera que les résultats du S1 (publication le 2 septembre) devraient être bons, malgré les charges liées au plan de rémunérati...Co. specializes in the field of in vitro diagnostics for clinical and industrial applications. Co. designs, develops, manufactures and markets systems used in: Clinical Applications (the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory illnesses, as well as pathologies such as cardiovascular diseases and cancers, based on the analysis of biological samples such as blood, saliva or urine); and Industrial Applications (microbiological analysis of samples of finished or semi-finished products (or of the environment), chiefly in the food processing and biopharmaceutical industries), detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.